Glenn L. Cooper
Presidente en Lascaux Media LLC .
Cargos activos de Glenn L. Cooper
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Lascaux Media LLC | Presidente | - | - |
Historial de carrera de Glenn L. Cooper
Antiguos cargos conocidos de Glenn L. Cooper.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| REPLIGEN CORPORATION | Director/Miembro de la Junta | 25/08/2009 | 13/05/2020 |
| Independent Dir/Board Member | 25/08/2009 | 13/05/2020 | |
| GENTIUM S.P.A. (ADR) | Director/Miembro de la Junta | 10/11/2009 | 27/03/2013 |
| Independent Dir/Board Member | 01/10/2009 | 27/03/2013 | |
| FORTRESS BIOTECH, INC. | Director/Miembro de la Junta | 30/07/2010 | 01/12/2010 |
| Director Ejecutivo | 01/12/2010 | 01/04/2011 | |
| Presidente | 01/12/2010 | 02/01/2013 | |
Indevus Pharmaceuticals, Inc.
 Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | Director/Miembro de la Junta | 01/01/1993 | 16/12/1996 |
| Director Ejecutivo | 16/12/1996 | 01/01/2009 | |
| Presidente | 16/12/1996 | 01/01/2009 | |
Progenitor, Inc.
 Progenitor, Inc. BiotechnologyHealth Technology Progenitor, Inc. is an American private company. The firm develops pharmaceutical compounds for nervous system. The company is headquartered in Columbus, OH. | Presidente | 01/09/1992 | 01/06/1994 |
Lilly Research Center Ltd.
 Lilly Research Center Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly Research Center Ltd. is a British company. | Corporate Officer/Principal | 01/06/1987 | 01/07/1990 |
| Sphinx Pharmaceuticals Corp | Director de Operaciones | 01/08/1990 | - |
Formación de Glenn L. Cooper.
| Harvard College | Undergraduate Degree |
| Tufts University School of Medicine | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 9 |
| Reino Unido | 2 |
| Italia | 2 |
Operativa
| Director/Board Member | 4 |
| Chairman | 3 |
| Independent Dir/Board Member | 2 |
Sectorial
| Health Technology | 8 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| REPLIGEN CORPORATION | Health Technology |
| FORTRESS BIOTECH, INC. | Health Technology |
| Empresas privadas | 6 |
|---|---|
Progenitor, Inc.
Progenitor, Inc. BiotechnologyHealth Technology Progenitor, Inc. is an American private company. The firm develops pharmaceutical compounds for nervous system. The company is headquartered in Columbus, OH. | Health Technology |
| Sphinx Pharmaceuticals Corp | Health Technology |
Lilly Research Center Ltd.
Lilly Research Center Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly Research Center Ltd. is a British company. | Health Technology |
Gentium Srl
 Gentium Srl Pharmaceuticals: MajorHealth Technology Gentium SRL manufactures and develops biopharmaceutical products. It offers discovery, research, development and manufacture of drugs for the treatment and prevention of a variety of vascular diseases and conditions related to cancer and cancer treatments. The company was founded by Laura Iris Ferro and is headquartered in Villa Guardia, Italy. | Health Technology |
Indevus Pharmaceuticals, Inc.
Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | Health Technology |
| Lascaux Media LLC |
- Bolsa de valores
- Insiders
- Glenn L. Cooper
- Experiencia
